Behavioural health platform developer Brightline captured $72m in a round led by GV, while Gopuff is set to buy Siemens and ST-backed mobility software producer RideOS.

The GlaxoSmithKline and Celgene-backed immunotherapy developer has floated in the middle of its range on the Nasdaq Global Market.

The Mitsui-backed money transfer service formerly known as TransferWise was valued at $5bn in a secondary share sale almost a year ago.

University of Ulm spinout WITec has agreed to a $50m acquisition by Oxford Instruments, itself the first-ever spinout of University of Oxford.

11Street and CJ Group contributed to a $71.8m round for on-demand logistics provider Barogo while Eli Lilly helped provide $66m for macrocycle drug developer Circle Pharma.

The payment card technology provider, which counts Visa, CommerzBank, CreditEase and Mastercard as investors, has added about $190m to close its IPO.

Broad Institute and UPenn-linked cardiovascular disease drug developer Verve priced an upscaled initial public offering above its range.

GV and Novo-backed cardiovascular disease drug developer Verve priced an upscaled initial public offering above its range.

The marketing platform developer is using cash from the United Internet-backed round to acquire MomentFeed, a deal that will allow Rockfish to exit.

The solid-state battery maker will get a Nasdaq listing through the deal, which follows $161m in funding from investors including Ford, BMW, Sanoh, Hyundai, A123, Samsung and Solvay.